Seizure Rescue Medication: Caregiver Education in a Simulation Setting

Status Epilepticus Clinical Trial

Official title: Seizure Rescue Medication: Caregiver Education in a Simulation Setting

Status Completed

Clinical Trial Summary

1. Design an educational quality improvement program to assess the most effective educational approach on caregiver seizure RM application. The investigators hypothesize that this educational program will improve caregiver comfort, knowledge of emergent seizure care, and time to medication application.

Specifically, the aims include:

1. Create an educational video reviewing RM administration

2. Develop and validate a simulation training model/mannequin for rectal diazepam administration

3. Expand training to other seizure RMs (e.g. intranasal midazolam, buccal lorazepam) and transition the most effective educational model back to the clinics/bedside to standardize caregiver teaching throughout the department/hospital

Clinical Trial Description

The investigators will implement an intervention jointly with a simulation program to determine the most effective training model: verbal instructions, instructional video, or use of a mannequin. Caregivers will undergo a training curriculum, and 60 caregivers (20 assigned to each educational model) will be matched into three groups and assigned to participate in one of three educational models in the SIM Center. Pre-and post-training questionnaires will be distributed to assess provider knowledge and comfort level. Scoring of caregiver technique administering rectal diazepam to a mannequin and time to RM administration will be obtained to compare between the three educational arms of the study. Thirty additional patients (10 per group) will not receive an assessment of caregiver technique administering RM to the mannequin prior to the educational intervention to control for exposure to the mannequin. Ultimately, the most effective educational method in this simulation pilot study will be expanded to other RM types (e.g. intranasal midazolam, buccal lorazepam), standardized, and brought back to the clinics/bedside throughout the hospital. ;

Related Conditions & MeSH terms

• Seizures
• Status Epilepticus

• NCT number: NCT03562351
• Study type: Interventional
• Source: Boston Children's Hospital
• Status: Completed
• Phase: N/A
• Start date: July 1, 2018
• Completion date: September 17, 2019